Minimal residual disease assessment by flow cytometry in AML is an independant prognostic factor even after adjusting for cytogenetic/molecular abnormalities Meeting Abstract


Authors: Ganzel, C.; Sun, Z. X.; Gonen, M.; Patel, J. P.; Abdel-Wahab, O.; Fernandez, H. F.; Rowe, J. M.; Tallman, M. S.; Levine, R. L.; Paietta, E. M.
Abstract Title: Minimal residual disease assessment by flow cytometry in AML is an independant prognostic factor even after adjusting for cytogenetic/molecular abnormalities
Meeting Title: 56th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 124
Issue: 21
Meeting Dates: 2014 Dec 6-9
Meeting Location: San Francisco, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2014-12-06
Language: English
ACCESSION: WOS:000349233807123
PROVIDER: wos
Notes: Meeting Abstract: 1016 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos
MSK Authors
  1. Mithat Gonen
    716 Gonen
  2. Martin Stuart Tallman
    443 Tallman
  3. Ross Levine
    490 Levine
  4. Jay Prakash Patel
    53 Patel
  5. Chezi Yeehezkel Ganzel
    7 Ganzel